Gene regulation of pteridine reductase 1 in leishmania promastigotes and amastigotes using a full-length antisense construct
- PMID: 23914230
- PMCID: PMC3724142
Gene regulation of pteridine reductase 1 in leishmania promastigotes and amastigotes using a full-length antisense construct
Abstract
Background: Pteridine metabolic pathway is unusual features of Leishmania, which is necessary for the growth of parasite. Leishmania has evolved a complex and versatile pteridine salvage network which has the ability of scavenging a wide area of the conjugated and unconjugated pteridines especially folate and biopterin. In this study, we focus on the inhibition of ptr1 gene expression.
Methods: L. major ptr1 gene was cloned into pcDNA3 and digested using KpnI and BamHI. The gene was subcloned so that antisense will transcribe and called pcDNA-rPTR. Leishmania major was cultured and late logarithmic-phase promastigotes were harvested. The promastigotes were divided into two groups. One group was transfected with 50 µg of pcDNA-rPTR, whereas the other group was transfected with pcDNA3. Transfected cells were cultured and plated onto semi-solid media. Mouse pritonean macrophages were transfected using pcDNA-rPTR-tansfected promastigotes. Western blotting was performed on mouse transfected pritonean macrophages and extracts from transfected promastigotes of L. major using a L. major ptr1 antibody raised in rabbits.
Results: The PTR1 protein was not expressed in pcDNA-rPTR- tansfected promastigotes and mouse macrophage transfected with pcDNA-rPTR- tansfected promastigotes.
Conclusion: This approach might be used to study the pteridine salvage pathway in Leishmania or to assess the possibility of using gene expression inhibition in the treatment of leishmaniasis.
Keywords: Antisense; Gene regulation; Inhibition; Leishmania; Pteridine reductase 1.
Figures
References
-
- Ouellette M, Drummelsmith J, Elfadidi A, Kundig C, Richard D, Roy G. Pterin transport and metabolism in Leishmania and related trypanosomatid parasites. Int J Parasitol. 2002;32(4):385–398. - PubMed
-
- Scott DA, Coombs GH, Sanderson BE. Folate utilisation by Leishmania species and the identification of intracellular derivatives and folate- metabolizing enzymes. Mol Biochem Parasitol. 1987;23(2):139–149. - PubMed
-
- Callahan HL, Beverley SM. A member of the aldoketo reductase family confers methotrexate resistance in Leishmania . J Boil Chem. 1992;267(34):24165–24168. - PubMed
-
- Cunningham ML, Beverley SM. Pteridine salvage throughout the Leishmania infectious cycle: implications for antifolate chemotherapy. Mol Biochem Parasitol. 2001;113(2):199–213. - PubMed
-
- Nare B, Uuba J, Hardy L, Beverley SM. New approach to Leishmania chemotherapy: pteridine reductase 1 (ptr1) as a target and modulator of antifolate sensitivity. Parasitol. 1997;114(Suppl):S101–110. - PubMed
LinkOut - more resources
Full Text Sources